FARMACIA Y SALUD
PhD school
Vita-Salute San Raffaele University
Milán, ItaliaPublications in collaboration with researchers from Vita-Salute San Raffaele University (1)
2024
-
Comparison between tofacitinib and ustekinumab as a third-line therapy in refractory ulcerative colitis: A multicenter international study
United European Gastroenterology Journal